Medical Disposables & Supplies JMSE:MDS Stock Report Medical Disposables & Supplies Limited
JMSE:MDS Stock Report
MDS Stock Overview Engages in the distribution of healthcare and consumer products in Jamaica.
Rewards Risk Analysis See All Risk Checks Medical Disposables & Supplies Limited Competitors Price History & Performance
Summary of all time highs, changes and price drops for Medical Disposables & Supplies Historical stock prices Current Share Price JA$2.12 52 Week High JA$3.37 52 Week Low JA$1.75 Beta -0.42 11 Month Change -12.76% 3 Month Change 17.78% 1 Year Change -37.09% 33 Year Change -62.14% 5 Year Change -68.59% Change since IPO 0.95%
Recent News & Updates
Medical Disposables & Supplies Limited to Report Fiscal Year 2024 Final Results on Nov 29, 2024 Oct 29
Medical Disposables & Supplies Limited Announces Board Appointments Sep 10
Full year 2024 earnings released: JA$1.11 loss per share (vs JA$0.27 profit in FY 2023) Jul 20
New minor risk - Share price stability May 04 Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited Mar 28
Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023) Feb 15 See more updates
Medical Disposables & Supplies Limited to Report Fiscal Year 2024 Final Results on Nov 29, 2024 Oct 29
Medical Disposables & Supplies Limited Announces Board Appointments Sep 10
Full year 2024 earnings released: JA$1.11 loss per share (vs JA$0.27 profit in FY 2023) Jul 20
New minor risk - Share price stability May 04 Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited Mar 28
Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023) Feb 15
New major risk - Share price stability Dec 11
Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023) Nov 17
Investor sentiment deteriorates as stock falls 24% Oct 31
First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023) Aug 18
Investor sentiment improves as stock rises 16% Jul 14
Investor sentiment improves as stock rises 19% Jun 28
Investor sentiment improves as stock rises 17% Jun 07
Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022) Jun 03
Investor sentiment improves as stock rises 22% Apr 28
Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022) Feb 18
Investor sentiment improves as stock rises 18% Feb 02
Investor sentiment improved over the past week Jan 05
Upcoming dividend of JA$0.09 per share Dec 29
Investor sentiment improved over the past week Dec 13
Investor sentiment deteriorated over the past week Nov 25
Less than half of directors are independent Nov 18
Investor sentiment improved over the past week Oct 27
Investor sentiment deteriorated over the past week Aug 30
Investor sentiment improved over the past week Aug 15
Investor sentiment deteriorated over the past week Jun 16
Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021) Jun 02
Investor sentiment improved over the past week May 19
Investor sentiment improved over the past week Apr 28
Less than half of directors are independent Apr 27
Investor sentiment improved over the past week Feb 02
Investor sentiment improved over the past week Jan 14
Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021) Nov 13
Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021) Nov 13
Investor sentiment improved over the past week Nov 13
Investor sentiment improved over the past week Oct 02
Upcoming dividend of JA$0.07 per share Aug 17
First quarter 2022 earnings released: EPS JA$0.10 (vs JA$0.03 loss in 1Q 2021) Aug 12
Full year 2021 earnings released Jul 15
Investor sentiment deteriorated over the past week Jun 29
Investor sentiment deteriorated over the past week Jun 09
Investor sentiment improved over the past week May 22
Investor sentiment improved over the past week May 05
New 90-day high: JA$4.74 Mar 12
Third quarter 2021 earnings released: EPS JA$0.10 (vs JA$0.02 in 3Q 2020) Feb 13
Second quarter 2021 earnings released: JA$0.02 loss per share Nov 09
Market pulls back on stock over the past week Oct 17
New 90-day low: JA$4.30 Oct 15
New 90-day low - JA$4.67 Sep 01
First quarter earnings released Aug 17
New 90-day low - JA$5.07 Jul 29 Shareholder Returns MDS JM Healthcare JM Market 7D -6.6% -2.1% -1.0% 1Y -37.1% -1.3% 3.2%
See full shareholder returns
Return vs Market: MDS underperformed the JM Market which returned 3.2% over the past year.
Price Volatility Is MDS's price volatile compared to industry and market? MDS volatility MDS Average Weekly Movement 14.0% Healthcare Industry Average Movement 6.3% Market Average Movement 8.5% 10% most volatile stocks in JM Market 16.1% 10% least volatile stocks in JM Market 4.0%
Stable Share Price: MDS's share price has been volatile over the past 3 months compared to the JM market.
Volatility Over Time: MDS's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of JM stocks.
About the Company Medical Disposables & Supplies Limited engages in the distribution of healthcare and consumer products in Jamaica. The company operates through three segments: Pharmaceuticals, Medical, and Consumables. It offers healthcare and consumables in the areas of pharmaceuticals, medical sundries, consumer goods, dental supplies; and disposable hospital items and equipment.
Show more Medical Disposables & Supplies Limited Fundamentals Summary How do Medical Disposables & Supplies's earnings and revenue compare to its market cap? MDS fundamental statistics Market cap JA$557.89m Earnings (TTM ) -JA$286.15m Revenue (TTM ) JA$3.76b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) MDS income statement (TTM ) Revenue JA$3.76b Cost of Revenue JA$3.04b Gross Profit JA$719.88m Other Expenses JA$1.01b Earnings -JA$286.15m
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 29, 2024
Earnings per share (EPS) -1.09 Gross Margin 19.16% Net Profit Margin -7.62% Debt/Equity Ratio 118.1%
How did MDS perform over the long term?
See historical performance and comparison
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
